May 15, 2024
The current Ozempic shortage has been driven by the increase in demand as the drug is being used to treat obese patients for long term weight management, in addition to the original group of type 2 diabetes patients. A study run by the University College London (UCL),...
Apr 18, 2024
The vast majority of discounts available to Pharmacist and Dispensing Doctors are between 0% and 19.9%, with the average at 11%. Most manufacturers do not attempt to compete with parallel imports, as they see it, quite rightly, as competing with themselves. However,...
Feb 27, 2024
In Parliament his month questions were posed to Andrew Stephenson, Secretary of State for Health and Social Care by Peter Grant MP (SNP). He asked ‘What steps the Department is taking to ensure that there is an adequate supply of Oxcarbazepine for patients with...
Feb 8, 2024
WaveData conducted a comparison of the average market prices given to accounts (pharmacies and dispensing doctors) by respiratory product manufacturers. The average discounts given over a 10 year period are very consistent at 9%, which probably reflects the underlying...
Nov 9, 2023
It would seem sensible to assume that profitable products are less likely to suffer shortages, concessions and price spikes than products where profit is hard to come by. Charles Joynson, WaveData MD, compared the reimbursement price and the average market price for...
Oct 10, 2023
Charles Joynson, WaveData MD, drilled into this to see where the increase is coming from, demonstrating that it’s a mixture of parallel import and generics which are driving the rise. – Parallel imports have risen from £22.73 in Sept 2013 to 26.24 in August...
